Literature DB >> 6946420

Induction of hepatic synthesis of serum amyloid A protein and actin.

J F Morrow, R S Stearman, C G Peltzman, D A Potter.   

Abstract

Major changes in the mRNA population of murine liver occur after administration of bacterial lipopolysaccharide, an agent that causes increases in the concentrations of acute-phase serum proteins. The mRNA for one of these, serum amyloid A, is increased at least 500-fold compared to the normal level. It becomes one of the most abundant hepatic mRNAs, and serum amyloid A synthesis comprises about 2.5% of total hepatic protein synthesis in the acute-phase response. Its synthesis is tissue-specific in that amyloid A mRNA was not detected in the kidney, an important site of amyloid fibril accumulation. The protein synthesized in largest amount by acute-phase liver tissue in culture is cytoplasmic actin. Its relative rate of synthesis is increased about 5-fold compared to the normal tissue; that of serum albumin is decreased to about one-third of its normal rate. The concentration of mRNA for serum albumin is decreased by a similar amount. Starting with induced liver RNA, we have constructed a recombinant plasmid containing most of the DNA sequence encoding the serum amyloid A polypeptide.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6946420      PMCID: PMC320234          DOI: 10.1073/pnas.78.8.4718

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Actin amino-acid sequences. Comparison of actins from calf thymus, bovine brain, and SV40-transformed mouse 3T3 cells with rabbit skeletal muscle actin.

Authors:  J Vandekerckhove; K Weber
Journal:  Eur J Biochem       Date:  1978-10-16

2.  High resolution two-dimensional electrophoresis of human plasma proteins.

Authors:  L Anderson; N G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Multiple genes coding for the androgen-regulated major urinary proteins of the mouse.

Authors:  N D Hastie; W A Held; J J Toole
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

4.  Effect of purified protein SAA on immune response in vitro: mechanisms of suppression.

Authors:  M D Benson; M Aldo-Benson
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

5.  Polymorphism of tissue and serum amyloid A (AA and SAA) proteins in the mouse.

Authors:  P D Gorevic; Y Levo; B Frangione; E C Franklin
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

6.  Serum amyloid A: evidence for its origin in polymorphonuclear leukocytes.

Authors:  C J Rosenthal; L Sullivan
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

7.  Induction of the acute-phase serum protein SAA requires both RNA and protein synthesis.

Authors:  J D Sipe
Journal:  Br J Exp Pathol       Date:  1978-06

8.  Glucocorticoid induction of hepatic alpha2u-globulin synthesis and messenger RNA level in castrated male rats in vivo.

Authors:  D T Kurtz; K M Chan; P Feigelson
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

9.  Localization of amyloid-related serum protein SAA-like material to intermediate (10 nm) filaments of cultured human embryonal fibroblasts.

Authors:  E Linder; V P Lehto; I Virtanen; S Stenman; J B Natvig
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

10.  Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.

Authors:  I Kushner; G Feldmann
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  45 in total

1.  Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells.

Authors:  X Li; W S Liao
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

2.  Structure of the human alpha 1-acid glycoprotein gene: sequence homology with other human acute phase protein genes.

Authors:  L Dente; G Ciliberto; R Cortese
Journal:  Nucleic Acids Res       Date:  1985-06-11       Impact factor: 16.971

3.  Regulation of mouse serum amyloid A gene expression in transfected hepatoma cells.

Authors:  J H Huang; H Y Rienhoff; W S Liao
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

4.  Serum amyloid A protein-related mRNA expression in herpes simplex virus type 2-transformed hamster cells.

Authors:  C Gervais; M Suh
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers.

Authors:  Glenn J Rapsinski; Tiffanny N Newman; Gertrude O Oppong; Jos P M van Putten; Çagla Tükel
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

6.  Serum amyloid A in the mouse. Sites of uptake and mRNA expression.

Authors:  R L Meek; N Eriksen; E P Benditt
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

7.  Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.

Authors:  I Hardardóttir; A H Moser; J Fuller; C Fielding; K Feingold; C Grünfeld
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Mapping of the mouse serum amyloid A gene cluster by long-range polymerase chain reaction.

Authors:  A Butler; A S Whitehead
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

9.  Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters.

Authors:  I Hardardóttir; S T Kunitake; A H Moser; W T Doerrler; J H Rapp; C Grünfeld; K R Feingold
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Measurement of serum amyloid A protein concentrations as test of renal allograft rejection in patients with initially non-functioning grafts.

Authors:  C P Maury; A M Teppo; J Ahonen; E von Willebrand
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.